In a recent study, ages at menarche and menopause, as well as pregnancy history, impacted the risk of endometrial cancer.

The presence of NAFLD increased from 25.3% to 29.4% among patients receiving oral menopause hormone therapy.

This is part 2 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent study, women with premenstrual disorders were more likely to experience early menopause and vasomotor symptoms.